CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T CellsMatthias Braun, Tobias Bald, Amelia Roman Aguilera et al.|Immunity|2020Cited by 181
Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccineChristopher L. D. McMillan, David A. Muller, Benjamin Liang et al.|Science Advances|2021Cited by 47
Complete protection by a single dose skin patch delivered SARS-CoV-2 spike vaccineChristopher L. D. McMillan, David A. Muller, Jovin J. Y. Choo et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 14
Tumor CD155 Drives Resistance to Immunotherapy by Downregulating the Activating Receptor CD226 in CD8 <sup>+</sup> T CellsMatthias Braun, Tobias Bald, Indrajit Das et al.|SSRN Electronic Journal|2019Cited by 3